Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Offringa

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Leukemia|August 26, 2006
BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopesJ H Kessler, S A Bres-Vloemans, P A van Veelen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR moleculesS H van der Burg, K M Kwappenberg, A Geluk, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Psychological Medicine|September 13, 2017
Diminished medial prefrontal cortex activation during the recollection of stressful events is an acquired characteristic of PTSDM K Dahlgren, L M Laifer, M B VanElzakker, et al.
European Journal of Immunology|February 13, 2001
Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancerS H van der Burg, K de Cock, A G Menon, et al.
Cancer Research|March 4, 1998
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cellsM L De Bruijn, D H Schuurhuis, M P Vierboom, et al.
Vaccine|September 26, 2002
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccineA de Jong, T O'Neill, A Y Khan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinomaM E Ressing, W J van Driel, R M Brandt, et al.
International Journal of Cancer|March 27, 2001
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopesS H van der Burg, M E Ressing, K M Kwappenberg, et al.
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Leukemia|August 26, 2006
BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopesJ H Kessler, S A Bres-Vloemans, P A van Veelen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR moleculesS H van der Burg, K M Kwappenberg, A Geluk, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Psychological Medicine|September 13, 2017
Diminished medial prefrontal cortex activation during the recollection of stressful events is an acquired characteristic of PTSDM K Dahlgren, L M Laifer, M B VanElzakker, et al.
European Journal of Immunology|February 13, 2001
Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancerS H van der Burg, K de Cock, A G Menon, et al.
Cancer Research|March 4, 1998
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cellsM L De Bruijn, D H Schuurhuis, M P Vierboom, et al.
Vaccine|September 26, 2002
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccineA de Jong, T O'Neill, A Y Khan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinomaM E Ressing, W J van Driel, R M Brandt, et al.
International Journal of Cancer|March 27, 2001
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopesS H van der Burg, M E Ressing, K M Kwappenberg, et al.
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Pageof 10